Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD.
Pulmonary inflammation and bacterial colonization are central to the pathogenesis of chronic obstructive pulmonary disease (COPD). Defects in macrophage phagocytosis of both bacteria and apoptotic cells contribute to the COPD phenotype. Small molecule inhibitors with anti-inflammatory activity again...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0163139&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850232499068731392 |
|---|---|
| author | Martin A Bewley Kylie B R Belchamber Kirandeep K Chana Richard C Budd Gavin Donaldson Jadwiga A Wedzicha Christopher E Brightling Iain Kilty Louise E Donnelly Peter J Barnes Dave Singh Moira K B Whyte David H Dockrell COPDMAP |
| author_facet | Martin A Bewley Kylie B R Belchamber Kirandeep K Chana Richard C Budd Gavin Donaldson Jadwiga A Wedzicha Christopher E Brightling Iain Kilty Louise E Donnelly Peter J Barnes Dave Singh Moira K B Whyte David H Dockrell COPDMAP |
| author_sort | Martin A Bewley |
| collection | DOAJ |
| description | Pulmonary inflammation and bacterial colonization are central to the pathogenesis of chronic obstructive pulmonary disease (COPD). Defects in macrophage phagocytosis of both bacteria and apoptotic cells contribute to the COPD phenotype. Small molecule inhibitors with anti-inflammatory activity against p38 mitogen activated protein kinases (MAPKs), phosphatidyl-inositol-3 kinase (PI3K) and Rho kinase (ROCK) are being investigated as novel therapeutics in COPD. Concerns exist, however, about off-target effects. We investigated the effect of p38 MAPK inhibitors (VX745 and SCIO469), specific inhibitors of PI3K α (NVS-P13K-2), δ (NVS-P13K-3) or γ (NVS-P13K-5) and a ROCK inhibitor PF4950834 on macrophage phagocytosis, early intracellular killing of bacteria and efferocytosis of apoptotic neutrophils. Alveolar macrophages (AM) obtained from broncho-alveolar lavage (BAL) or monocyte-derived macrophages (MDM) from COPD patients (GOLD stage II/III) enrolled from a well characterized clinical cohort (MRC COPD-MAP consortium) or from healthy ex-smoker controls were studied. Both COPD AM and MDM exhibited lower levels of bacterial phagocytosis (using Streptococcus pneumoniae and non-typeable Haemophilus influenzae) and efferocytosis than healthy controls. None of the inhibitors altered bacterial internalization or early intracellular bacterial killing in AM or MDM. Conversely PF4950834, but not other inhibitors, enhanced efferocytosis in COPD AM and MDM. These results suggest none of these inhibitors are likely to exacerbate phagocytosis-related defects in COPD, while confirming ROCK inhibitors can enhance efferocytosis in COPD. |
| format | Article |
| id | doaj-art-93b4546360fc4a8381bc77a1fb98b2dd |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-93b4546360fc4a8381bc77a1fb98b2dd2025-08-20T02:03:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01119e016313910.1371/journal.pone.0163139Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD.Martin A BewleyKylie B R BelchamberKirandeep K ChanaRichard C BuddGavin DonaldsonJadwiga A WedzichaChristopher E BrightlingIain KiltyLouise E DonnellyPeter J BarnesDave SinghMoira K B WhyteDavid H DockrellCOPDMAPPulmonary inflammation and bacterial colonization are central to the pathogenesis of chronic obstructive pulmonary disease (COPD). Defects in macrophage phagocytosis of both bacteria and apoptotic cells contribute to the COPD phenotype. Small molecule inhibitors with anti-inflammatory activity against p38 mitogen activated protein kinases (MAPKs), phosphatidyl-inositol-3 kinase (PI3K) and Rho kinase (ROCK) are being investigated as novel therapeutics in COPD. Concerns exist, however, about off-target effects. We investigated the effect of p38 MAPK inhibitors (VX745 and SCIO469), specific inhibitors of PI3K α (NVS-P13K-2), δ (NVS-P13K-3) or γ (NVS-P13K-5) and a ROCK inhibitor PF4950834 on macrophage phagocytosis, early intracellular killing of bacteria and efferocytosis of apoptotic neutrophils. Alveolar macrophages (AM) obtained from broncho-alveolar lavage (BAL) or monocyte-derived macrophages (MDM) from COPD patients (GOLD stage II/III) enrolled from a well characterized clinical cohort (MRC COPD-MAP consortium) or from healthy ex-smoker controls were studied. Both COPD AM and MDM exhibited lower levels of bacterial phagocytosis (using Streptococcus pneumoniae and non-typeable Haemophilus influenzae) and efferocytosis than healthy controls. None of the inhibitors altered bacterial internalization or early intracellular bacterial killing in AM or MDM. Conversely PF4950834, but not other inhibitors, enhanced efferocytosis in COPD AM and MDM. These results suggest none of these inhibitors are likely to exacerbate phagocytosis-related defects in COPD, while confirming ROCK inhibitors can enhance efferocytosis in COPD.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0163139&type=printable |
| spellingShingle | Martin A Bewley Kylie B R Belchamber Kirandeep K Chana Richard C Budd Gavin Donaldson Jadwiga A Wedzicha Christopher E Brightling Iain Kilty Louise E Donnelly Peter J Barnes Dave Singh Moira K B Whyte David H Dockrell COPDMAP Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD. PLoS ONE |
| title | Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD. |
| title_full | Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD. |
| title_fullStr | Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD. |
| title_full_unstemmed | Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD. |
| title_short | Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD. |
| title_sort | differential effects of p38 mapk pi3k or rho kinase inhibitors on bacterial phagocytosis and efferocytosis by macrophages in copd |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0163139&type=printable |
| work_keys_str_mv | AT martinabewley differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT kyliebrbelchamber differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT kirandeepkchana differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT richardcbudd differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT gavindonaldson differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT jadwigaawedzicha differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT christopherebrightling differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT iainkilty differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT louiseedonnelly differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT peterjbarnes differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT davesingh differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT moirakbwhyte differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT davidhdockrell differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd AT copdmap differentialeffectsofp38mapkpi3korrhokinaseinhibitorsonbacterialphagocytosisandefferocytosisbymacrophagesincopd |